Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase 6 pseudogene 6 (MAPK6P6) is a processed genetic element classified as a pseudogene, meaning it is a DNA sequence similar to the functional MAPK6 gene but generally does not encode a protein or directly participate in cell biology[6][5]. Pseudogenes like MAPK6P6 may occasionally affect gene regulation through mechanisms such as competing for regulatory molecules, acting as miRNA decoys, or influencing mRNA stability, but these functions are not established for MAPK6P6 specifically[2]. There is no evidence for direct involvement in signaling, disease pathways, or interaction with pharmaceuticals. The designation “mitogen-activated protein kinase 6 pseudogene 6” reflects its genetic relationship to the genuine mitogen-activated protein kinase 6 (MAPK6), an enzyme involved in signal transduction, cell cycle regulation, and cancer biology[1][3]. However, MAPK6P6 itself lacks these canonical protein functions and is not regarded as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase 6 pseudogene 6 (MAPK6P6).